MelliCell
Phase 1MelliCell Inc. pioneers next-generation therapeutics for chronic diseases like diabetes and obesity through advanced fat cell engineering. Utilizing proprietary technology, we generate mature human adipose tissue in vitro, unlocking new avenues for treatment, tissue engineering, and regenerative medicine. Our innovative approach aims to transform fat cells into powerful tools for health improvement.
About
MelliCell Inc. pioneers next-generation therapeutics for chronic diseases like diabetes and obesity through advanced fat cell engineering. Utilizing proprietary technology, we generate mature human adipose tissue in vitro, unlocking new avenues for treatment, tissue engineering, and regenerative medicine. Our innovative approach aims to transform fat cells into powerful tools for health improvement.
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile